Artichoke (Cynara scolymus L.) extracts are showing concentration-dependent hormetic and cytotoxic effects on breast cancer cell lines by Vigh, Szabolcs et al.
Studia Universitatis “Vasile Goldiş”, Seria Ştiinţele Vieţii 
Vol. 26 issue 4, 2016, pp.423- 433 
© 2016 Vasile Goldis University Press (www.studiauniversitatis.ro) 
 
 
Correspondence*:  Endre Máthé Vasile Goldiş” Western University of Arad, Faculty of Medicine, Liviu Rebreanu Str.91-93, RO-
310414, Arad, Romania, University of Nyíregyháza, Agricultural and Molecular Research Institute, Sóstói str. 31/B, H-4432, 
Nyíregyháza, Hungary, University of Debrecen, Faculty of Agriculture and Food Sciences and Environmental Management, 
Böszörményi str. 138, H-4032 Debrecen, Hungary,  endre.mathe64@gmail.com 
ARTICHOKE (CYNARA SCOLYMUS L.) EXTRACTS  ARE SHOWING 
CONCENTRATION-DEPENDENT HORMETIC AND CYTOTOXIC 
EFFECTS ON BREAST CANCER CELL LINES  
 
Szabolcs Vígh
1,2,
, Zsanett Zsvér-Vadas
2
, Ciprian Pribac
3
, Liana Moş
3
, Zoltán Cziáky
2
, Mária Czapár
2
, 
Ciprian Valentin Mihali
5
, Violeta Turcuş
3
, Endre Máthé
2,3,4
* 
 
1
 University of Nyíregyháza, Institute of Agricultural Sciences, Nyíregyháza, Hungary, 
2
 University of Nyíregyháza, Agricultural and Molecular Research Institute, Nyíregyháza, Hungary 
3 
“Vasile Goldiş” Western University of Arad, Faculty of Medicine, Arad, Romania 
4 
University of Debrecen, Faculty of Agriculture and Food Sciences and Environmental Management, 
Debrecen, Hungary 
 
5 
“Vasile Goldiş” Western University of Arad, Institute of Life Scinces, Arad, Romania 
 
ABSTRACT: Chemomapping of artichoke (Cynara scolymus L.) leaf extracts revealed novel bioactive 
compounds with putative anti-tumor effects, and therefore, we set to analyze the cytotoxic effects of aqueous 
and alcoholic extracts on T-47D and ZR-75-1 human breast cancer cell lines. A concentration dependent 
hormetic response was detected in the case of aqueous extract, while the alcoholic extract featured a 
pronounced cytotoxic effect as inferred by the MTT proliferation assays. Immunocytochemical analyses of 
treated cells were suggesting that the observed cytotoxicity could be associated with cellular senescence 
and/or apoptosis. Our experimental data are suggesting that the artichoke could be a good candidate for the 
complementary treatment of certain human cancers but further studies are needed to shed light on all 
aspects related to its hormetic dose response and cytotoxic effect not talking about the putative 
hepatoprotective effect in relation to cancer therapy efficiency.       
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INTRODUCTION: 
The artichoke - Cynara scolymus L. -  is emerging 
like a promising medicinal plant as its extracts are 
featuring a high degree of consistency regarding the 
generated effects across experimental and clinical trials 
(for review see Ben Salem et al., 2015). Among health-
promoting properties there were identified and 
thoroughly characterized the antioxidant, 
cardiovascular-and hepato-protective, choleretic, 
postprandial hypoglycemic, hypocholesterolemic, 
hypotriglyceridaemic and prebiotic effects.  
Several antioxidant bioactive compounds had been 
identified in globe artichoke, and their antioxidant 
activity were confirmed in multiple pre-clinical studies 
(Betancor-Fernandez et al., 2003; Wang et al., 2003; 
Llorach, 2002; Fintelmann, 1996a; Adzet et al., 1987). 
Further studies were indicating an antioxidant-based 
hepatoprotective effect based on rat hepatocytes 
cultured endothelial cells (Gebhardt and Fausel, 1997; 
Gebhardt, 1995; Adzet et al., 1987), monocytes 
(Zapolska-Downar et al., 2002), and an in vivo rat 
model (Magielse et al., 2014; Jimenez-Escrig et al., 
2003). Hepatoprotective effect of artichoke was 
associated with its polyphenolic content that could 
counteract lipid peroxidation, occurring at the 
membraneous structures of rat hepatocytes (Gebhardt, 
1995), and also by facilitating bile production assisted 
fat digestion (Kraft, 1997) together with toxin removal 
(Fintelmann, 1996b).The antioxidants of artichoke 
were also suggested to inhibit the oxidation of LDL 
(Brown and Rice-Evans, 1998).  
The cardiovascular protective effect of artichoke 
was proposed to be associated partly with the up 
regulation of endothelial nitric oxide synthase (eNOS) 
gene expression leading to an increased nitric oxide 
production and vasodilator activity as inferred from 
cultured human umbilical vein endothelial cells (Li et 
al., 2004; Lupattelli et al., 2004). Moreover, the 
hypocholesterolemic effect of artichoke might bring a 
substantial contribution to cardiovascular protection. 
Initially, the cynarin, a polyphenol component of 
artichoke extracts, was proposed to reduce serum 
cholesterol and triglyceride levels based on in vitro and 
animal studies (Lietti, 1997; Wojcicki, 1978). 
However, the luteolin, a flavonoid from artichoke, was 
found to be responsible for inhibition of cholesterol 
synthesis, while cynarin had no effect on cholesterol 
synthesis (Gebhardt, 1996). Other white rat based 
research was showing that artichoke extracts may 
prevent the development of atherosclerotic plaques 
(Samochowiec, 1962). The antiatherosclerotic action 
was suggested to be the result of an antioxidant effect 
that reduces LDL oxidation (Brown and Rice-Evans, 
1998), and the inhibition of cholesterol synthesis 
(Wegener, 1995). More recently, both caffeoylquinic 
acids and luteolin glucosides were proposed to be 
responsible for the antiatherogenic effects of artichoke 
(Wang et al., 2003). Other observations showed that 
the artichoke exerted positive effects on serum lipid 
profile together with blood glucose levels. Moreover, 
artichoke leaf extract had been proven to increase the 
anti-inflammatory response in non-alcoholic 
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steatohepatitis induced rats (Safaa et al., 2013) and 
non-alcoholic fatty liver patients (Rangboo et al., 
2016). 
The anti-tumoral effects of artichoke extracts have 
also been analyzed, and it was observed that 
antioxidants such us rutin, quercetin and gallic acid 
were able to reduce viability of leukemia cells by 
inducing apoptosis (Nadova et al., 2008). Experimental 
conditions when MDA-MB231 human breast cancer 
cells were incubated with the edible part extract of 
artichoke at high concentration and for shorter time 
interval, made the apoptotic program activated and 
tumor progression arrested (Mileo et al., 2012). 
However, at lower concentration of extract exposure 
and longer incubation intervals, the brest cancer cell 
growth had been inhibited via senescence through 
epigenetic and ROS-mediated mechanisms (Mileo et 
al., 2015). Polyphenolic extracts made from the edible 
part of artichoke reduced cellular viability in the case 
of human liver cancer HepG2 inducing apoptosis in a 
dose-dependent manner (Miccadei et al., 2008). Wild 
and cultivated artichoke species vegetative parts were 
used to make extracts, and subsequently test them, 
using DLD1 colorectal cancer cells (Simsek and Uysal, 
2013). Such treated cells entered apoptosis having their 
DNA fragmented, while the induction of pro-apoptotic 
BAX gene and inhibition of anti-apoptotic BCL-2 gene 
expressions were observable. Cultured malignant 
pleural mesothelioma cells showed pronounced 
cytotoxicity when treated with artichoke leaf extract, 
and the identified misregulated pathways were related 
to cancer initiation and progression (Sharma et al., 
2016). In order to assign the observed effects to 
bioactive compounds, an in silico target prediction has 
revealed 47 compounds in relation to 93 genes that are 
involved in cancer progression, survival and resistance, 
including activation of apoptosis and restraining 
invasion (Sharma et al., 2016; Pulito et al., 2015).  
In a previous study using UHPLC-ESI-MS 
technique, we have carried out the qualitative 
chemomapping of aqueous and alcoholic artichoke leaf 
extracts, and could identify 48 and 50 bioactive 
compounds, respectively (Vígh et al., unpublished 
results). Individual assessment of the newly found 
bioactive compounds in artichoke extracts were 
indicating anti-tumoral properties in the case of 7-
methoxy-4-methylcoumarin, diosmetin, salvigenin, 
naringin and ursolic acid. Moreover, our studies have 
confirmed the presence of rutin, quercetin and vitamin 
B6 in artichoke leaf extracts, and these are bioactive 
compounds whose anti-tumoral effects have been 
reported in earlier studies (Mocellin et al., 2016; Orfali 
et al., 2016; de Araújo et al., 2013).  Some published 
papers associated the artichoke specific anti-tumoral 
effect with its antioxidant properties, and the later was 
considered to be related to the polyphenol and 
flavonoid content of the obtained extracts (Miccadei et 
al., 2008; Nadova et al., 2008). It is also interesting to 
notice that there are significant differences between the 
bioactive compound profiles of our artichoke leaf 
extracts, so that most strikingly, very few polyphenols 
were detected in alcoholic extracts as compared to the 
aqueous, while in the case of flavonoids did exist only 
few differences between the two artichoke leaf 
extracts. The above mentioned differences prompted us 
to assess the putative cytotoxicity of aqueous and 
alcoholic artichoke leaf extracts on T-47D and ZR-75-
1 human breast cancer cell lines. We were able to 
detect a concentration-dependent hormetic response for 
the aqueous extract, while the alcoholic extract showed 
marked cytotoxicity as inferred by the MTT 
proliferation assays performed at different time 
intervals on cancerous cell lines. Immunocytochemical 
analyses of treated cells were suggesting that the 
observed cytotoxicity could be associated with cellular 
senescence and/or apoptosis.    
 
MATERIALS AND METHODS: 
Preparation of plant extract 
Dried artichoke leaves were obtained from TTDR 
2000 Ltd., Hungary. 10 g of dried artichoke leaves 
were extracted within 200 ml boiling distilled water for 
5 min. The obtained primary extract was allowed to 
cool down at room temperature, then filtered and 
stored in refrigerator. Such an extract was named 
„aqueous artichoke extract” (AqA). To obtain the 
alcoholic extract 50 g of dried artichoke leaves were 
extracted twice with 500 ml 50% ethanol solution by 
stirring for 4 hours on a magnetic stirrer at room 
temperature. As a result, primary alcoholic extracts 
were obtained that later were mixed together, filtered 
then evaporated under vacuum and stored in 
refrigerator. Such an extract was named „alcoholic 
artichoke extract” (AlA).  
 
Cell culture 
Human breast cancer cell lines T-47D and ZR-75-1 
were obtained from ATCC (American Type Culture 
Colection, USA). These ductal carcinoma cell lines 
were grown in RPMI-1640 (Lonza) culture medium 
supplemented with 1% Antibiotic Antimycotic 
Solution (Invitrogen-Gibco), 10% heat-inactivated FBS 
(Fetal Bovine Serum; Sigma) and 0,1% 1 mM Na-
pyruvate (Biochromag). All cell culture experiments 
were carried out at 37°C in 5% CO2 incubator. 
 
MTT (cytotoxicity) assay 
Cells were used in this studies when 80% 
confluence was reached in T75 flasks (Greiner Bio-
One GmbH). Cells were washed twice with sterile 
PBS, and harvested with Trypsin in the incubator. For 
counting the cells we used Trypan blue dye (Sigma) 
exclusion method and counted with Bürker chamber. 
After it the cells were seeded into 96-well plates at a 
density of 10
4 
cells/well and left to attach to the plates. 
After 24 hours cells were incubated for two and three 
days with various concentrations (10-5-2.5-1.25-0.62-
0.31-0.16-0.08-0.04 v/v%) of extracts. After the 
exposure time removed the extracts and the cells were 
incubated with ten microliter of MTT (5 mg/ml) (3-
[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium 
bromide) (Sigma) at 37°C for three hours. After 
dissolving the formazan crystals in MTT solubilization 
solution, plates were read in a microplate reader 
(BioTek EL808) at 570 nm. This experiment was 
performed in sextuplicates and repeated three times.
 
Artichoke (Cynara scolymus L.) extracts are showing concentration-dependent hormetic and cytotoxic  
effects on breast cancer cell lines 
 
Studia Universitatis “Vasile Goldiş”, Seria Ştiinţele Vieţii 
Vol. 26 issue 4, 2016, pp.423- 433 
© 2016 Vasile Goldis University Press (www.studiauniversitatis.ro) 
425 
Immunostaining and microscopy 
The treatments with both artichoke extracts were 
carried out in six-well plates and at the examined 
concentration range. At the bottom of each well, a 
coverslip was laid and cells were let to grow on the 
surface of coverslip.  After 2- and 3–day treatments the 
cells were fixed with formaldehyde and stained as 
described by Mathe et al. (2004) and Lemos et al. 
(2000). The microtubules were detected with YL1/2 rat 
monoclonal anti-α-tubulin antibody (Sera Lab, Inc.), 
while the DNA was counterstained with the DAPI dye 
(Molecular Probes). Digital images of optical sections 
were collected with an Olympus CellR fluorescent 
microscope. 
Statistical analysis 
Statistical analysis were performed by the SPSS 
16.0 software. Statistical differences among treated and 
untreated cells were determined by one-way ANOVA 
(Analysis of Variance). To compare several groups, 
Tukey post-hoc test was applied and mean differences 
with p< 0.05 were considered statistically significant. 
 
RESULTS AND DISCUSSION:  
In order to gain more information about the 
possible effects exerted by the artichoke extracts on 
human cancerous breast cells, we set to analyze T-47D 
and ZR-75-1 cell lines. The T-47D is classified like a 
luminal A subtype of breast cancer cell line that is 
endocrine (oestrogen receptor expression) and often 
chemotherapy responsive (Holliday and Speirs, 2011). 
The ZR-75-1 is luminal B subtype of breast cancer cell 
line being usually endocrine responsive and variable to 
chemotherapy. The luminal A and B subtypes are 
amenable to hormone therapy. Interestingly, genomic 
differences were detected between certain breast 
cancerous cell lines, like the T-47D cells are having the 
mutant allele of p53 gene, while ZR-75-1 cells are 
bearing the normal p53 allele (Huovinen et al., 2011). 
It had been also demonstrated that ZR-75-1 cells are 
containing the normal BRCA1/2 allele (Gilardini 
Montani et al., 2013). Surprisingly, the hMAT gene 
expression shows a 10-fold increase in T-47D cells as 
compared to the normal expression levels detected for 
the ZR-75-1 cells (Bandyopadhyay et al., 1996). All 
the above mentioned differences are suggesting that the 
T-47D and ZR-75-1 cell lines representing different 
subtypes of breast cancer could have different 
prognosis and treatment response.  
 
Aqueous artichoke leaf extract induces hormetic 
response associated cytotoxicity on T-47D cultured 
cells 
To investigate whether the aqueous artichoke 
extract could influence the viability of T-47D breast 
cancer cells, 2 to 3 days long treatments were carried 
out in culture media containing the dilution series of 
the original extract and MTT assays were carried out 
(see Fig. 1 and 2). Interestingly, in the case of the 2-
day treatment, we could observe in the case of 10 – 
0.63% concentration range of aqueous artichoke 
extract that the treated cancerous cell viability was 
approximately 4 times reduced as compared to the 
control untreated cells. It seems likely that the 0.31% 
concentration could be considered the LD50 value in 
this experiment. Throughout the 0.16 – 0.04% extract-
specific concentration interval, the viability of the 
treated cells steadily increased, so that at 0.08% and 
0.04% concentrations their viability exceeded 
approximately 1.3 times those of the untreated control 
cells. 
    
 
 
 
 
Fig. 1 Cell viability after 2-day treatment using aqueous artichoke extract. The T-47D cell viability was measured by MTT 
assay. The applied concentrations are indicated in %. C-stands for untreated or positive control cells. Blue line indicates 
the presumptive LD50. MTT- represents the negative control. One-Way ANOVA Tukey test was used for statistical 
analysis. Different letters on columns indicate statistical significance at p<0.05.    
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Looking at the 3-day treatment experiments, in the 10 
– 0.63% concentration range of aqueous artichoke 
extract, the viability of treated cancerous cells was 5 
times reduced, yet constant, throughout the assessed 
concentration values as compared to control untreated 
cells (see Fig.2). It seems likely that the 0.31% 
concentration could be close to the LD50 value in this 
experiment. Started from the 0.16% concentration 
point, and ended with the 0.04% concentration of 
artichoke leaf extract, the viability of treated cells was 
increasing progressively. At 0.08% and 0.04% extract 
concentrations, the viability of treated cells surpassed 
approximately 1.5 times the values of untreated 
control cells. In this respect, the 3-day treatment 
recapitulates the 2-day experiment, though the 
increased number of viable cells was evident.    
  
 
 
Fig. 2 Cell viability after 3-day treatment using aqueous artichoke extract. The T-47D cell viability was measured by MTT 
assay. The applied concentrations are indicated in %. C-stands for untreated or positive control cells. Blue line indicates 
the presumptive LD50. MTT- represents the negative control. One-Way ANOVA Tukey test was used for statistical 
analysis. Different letters on columns indicate statistical significance at p<0.05.    
 
Alcoholic artichoke leaf extract induces marked 
cytotoxicity on T-47D cultured cells 
We have assessed the alcoholic artichoke extract 
effect regarding the viability of T-47D breast cancer 
cells in 2 to 3 days long treatments in culture media 
containing the dilution series of the original extract 
(see Fig. 1 and 2). In 2-day treatment experiments, we 
could observe in the 10 – 0.08% concentration range 
that the treated cancerous cell viability was greatly 
reduced. Among the observed low viability values 
some fluctuations did occur. Therefore, in the 10-
1.25% concentration range the viability of treated cells 
was approximately 8 times lower compared to control 
cells. Similarly in the 0.63-0.08% concentration rage, 
the viability of treated cells increased, yet compared to 
controls was approximately 4 times lower. 
Nevertheless, in the case of the lowest applied 0.04% 
concentration, the viability of treated cells increased 
approximately   to 50% compared to control, meaning 
that this concentration might correspond to LD50 
value.  Taken together, we can conclude that the 
applied alcoholic artichoke extract concentrations are 
featuring toxicity. 
 
 
Fig. 3 Cell viability after 2-day treatment using alcoholic artichoke extract. The T-47D cell viability was measured by MTT 
assay. The applied concentrations are indicated in %. C-stands for untreated or positive control cells. Blue line indicates 
the presumptive LD50. MTT- represents the negative control. One-Way ANOVA Tukey test was used for statistical 
analysis. Different letters on columns indicate statistical significance at p<0.05.  
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At the 3-day treatment experiments, we could observe 
in the 10 – 0.08% concentration range that the 
viability was greatly reduced for treated cancerous 
cells. Throughout the above mentioned concentration 
range the low viability values show some degree of 
variation. Accordingly, in the 10-0.63% concentration 
range the viability of treated cells was approximately 
9 times lower as compared to control cells. In the 
0.31-0.08% concentration rage, the viability of treated 
cells increased, yet compared to controls was 
approximately 5.5 times lower. Nevertheless, in the 
case of the applied lowest 0.04% concentration, the 
viability of treated cells increased but, did not reach 
50%, suggesting that this working concentration does 
not corresponds to a LD50 value. We can conclude 
that the 3-day long applied alcoholic artichoke extract 
concentrations are featuring a greater level of toxicity 
than those observed in the 2-day treatment 
experiments.   
 
 
 
 
Fig. 4 Cell viability after 3-day treatment using alcoholic artichoke extract. The T-47D cell viability was measured by MTT 
assay. The applied concentrations are indicated in %. C-stands for untreated or positive control cells. Blue line indicates 
the presumptive LD50. MTT- represents the negative control. One-Way ANOVA Tukey test was used for statistical 
analysis. Different letters on columns indicate statistical significance at p<0.05.   
 
Aqueous artichoke leaf extract induces hormetic 
response associated cytotoxicity on ZR-75-1 
cultured cells 
We also assessed the aqueous artichoke effect on 
the viability of ZR-75-1 breast cancer cells by carrying 
out 2 and 3 days long treatments in culture media 
containing dilution series of the original extract (see 
Fig. 5 and 6). In the 2-day treatment, we observed for 
the 10 – 0.63% concentration range of aqueous 
artichoke extract that the treated cancerous cell 
viability was approximately 6 times lower than in 
control untreated cells. It is also interesting that the 
0.16% concentration would be the equivalent of the 
LD50 value in this experiment. Throughout the 0.16 – 
0.04% extract-specific concentration interval, the 
viability of the treated cells increased steadily, so that 
at 0.04% concentration the cell viability exceeded 1.2 
times those of the untreated control cells.    
 
 
 
Fig. 5 Cell viability after 2-day treatment using aqueous artichoke extract. The ZR-75-1 cell viability was measured by 
MTT assay. The applied concentrations are indicated in %.C-stands for untreated or positive control cells. Blue line 
indicates the presumptive LD50. MTT- represents the negative control. One-Way ANOVA Tukey test was used for 
statistical analysis. Different letters on columns indicate statistical significance at p<0.05.    
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Looking at the 3-day treatment experiments, in the 10 – 
0.31% concentration range of aqueous artichoke 
extract, the viability of treated cancerous cells was 
markedly reduced, yet constant, throughout the 
assessed concentrations at about 8.5 times lower 
viability was detected as compared to control untreated 
cells (see Fig.5). The 0.16% concentration could be 
considered the LD50 value in this experiment. In the 
0.08 - 0.04% concentration range of artichoke extract, 
the viability of treated cells was increasing 
progressively. At 0.04% extract concentration, the 
viability of treated cells surpassed 1.2 times the 
untreated control cells specific values. Therefore, the 
3-day treatment seems to recapitulate the 2-day 
experiment with respect to cell viability.   
 
 
 
Fig. 6 Cell viability after 3-day treatment using aqueous artichoke extract. The ZR-75-1 cell viability was measured by 
MTT assay. The applied concentrations are indicated in %. C-stands for untreated or positive control cells. Blue line 
indicates the presumptive LD50. MTT- represents the negative control. One-Way ANOVA Tukey test was used for 
statistical analysis. Different letters on columns indicate statistical significance at p<0.05.    
 
Alcoholic artichoke leaf extract features a marked 
cytotoxic effect in case of ZR-75-1 cultured cells 
We analyzed the alcoholic artichoke extract effect 
on the viability of ZR-75-1 breast cancer cells in 2 to 3 
days treatments in culture media containing the 
dilution series of the original extract (see Fig. 7 and 8). 
The 2-day treatment experiment showed that in the 10 
– 1.25% concentration range that the treated cancerous 
cell viability was critically reduced, so that the viability 
of treated cells was more than 10 times lower as 
compared to control cells. Next, in the 0.63-0.08% 
concentration rage, the viability of treated cells 
increased slightly but remained, being 7 times lower 
than the control value. In the case of the applied lowest 
0.04% concentration, the viability of treated cells 
increased but not substantially, and did not reach any 
value that would correspond to LD50. All these data 
are indicating that the applied alcoholic artichoke leaf 
extract featured pronounced toxicity in 2-day 
experiments. 
 
 
 
Fig. 7 Cell viability after 2-day treatment using alcoholic artichoke extract. The ZR-75-1 cell viability was measured by 
MTT assay. The applied concentrations are indicated in %.C-stands for untreated or positive control cells. Blue line 
indicates the presumptive LD50. MTT- represents the negative control. One-Way ANOVA Tukey test was used for 
statistical analysis. Different letters on columns indicate statistical significance at p<0.05. 
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At the 3-day treatment experiments, we could observe 
throughout the analyzed concentration range that the 
viability was greatly reduced for treated cancerous 
cells. The observed viability values showed some 
minor variation throughout the monitored 
concentrations but did not differ significantly from 
each other (see Fig.8). The viability of treated cells was 
approximately 13 times lower as compared to control 
cells. All the observed viability values were far from 
reaching the expected LD50 value. It is obvious that 
the 3-day treatment with alcoholic artichoke extract 
shows the most pronounced toxic effect on the ZR-75-
1 cancerous cell line.   
 
 
Fig. 8 Cell viability after 3-day treatment using alcoholic artichoke extract. The ZR-75-1 cell viability was measured by 
MTT assay. The applied concentrations are indicated in %. C-stands for untreated or positive control cells. Blue line 
indicates the presumptive LD50. MTT- represents the negative control. One-Way ANOVA Tukey test was used for 
statistical analysis. Different letters on columns indicate statistical significance at p<0.05. 
 
Immunostaining reveals senescence and apoptosis 
like effects in artichoke leaf extract treated breast 
cancer cells 
Having seen the above described viability reducing 
effects in the case of our artichoke leaf extracts treated 
cells we set to analyze the cells phenotype by assessing 
their chromosomal structure. Among the artichoke leaf 
extract treated cells we were able to detect some 
normal interphase and mitotic cells, but there were also 
polyploidy cells, binuclear cells, and cells showing 
minispindle and sometime multipolar spindle (Fig.9). 
The polyploidy cells quite often were showing 
overcondensed and/or fragmented chromosomes 
features that are specific to cells entering senescence 
and/or apoptosis. 
However, such an immunostaining does not allow us to 
quantify the observed phenotypes, but it indicates that 
further studies are needed based primarily on FACS to 
assess all the existed cells at a given time point and 
applied concentration. In this way a more precise 
picture will unfold regarding the cellular aspects of the 
cytotoxic effect generated by artichoke leaf extracts.  
 
   
  
Fig. 9 Immunostainigs of artichoke extract treated breast cancer cells.  
 
Note. A. Normal looking cells in interphase, at mitotic metaphase (arrow) and binucleated cell (star); green indicates microtubules, 
blue stands for DNA. B-C. Polyploidy cell with fragmented chromosomes and/or micronuclei (arrowhead). Minipindle with 
overcondensed chromosomes (arrow). Binucleated cell (star); green indicates microtubules, blue stands for DNA. C.  
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CONCLUSIONS: 
Our studies are indicating a pronounced cytotoxic 
effect for both aqueous and alcoholic artichoke leaf 
extracts on the T-47D, ZR-75-1 human breast cancer 
cell lines. The observed cytotoxic effect was more 
pronounced in the case of alcoholic artichoke leaf 
extract for both cell lines. Indirect evidences are 
indicating that the alcoholic artichoke extract is 
inducing apoptosis on the treated cells even at very low 
concentrations. In previous study we have analyzed the 
chemical composition of alcoholic and aqueous 
artichoke extracts, and we were able to detect some 
bioactive compounds only in the alcoholic extract 
(Vígh et al., accepted for publication). In the alcoholic 
artichoke leaf extract we could identify specific 
compounds like scopoletin, apigenin, diosmetin, 
isohoifolin, salvigenin, naringin dihydrochalcone, 
ursolic acid, stearidonic acid methyl ester and 
stearidonic ethyl ester, whose individual anti-tumoral 
properties have been already confirmed. It seems likely 
that these bioactive compounds by acting on different 
cellular mechanisms do produce a strong inhibitory 
effect on the viability of T-47D and ZR-75-1 human 
breast cancer cell lines. 
Interestingly, when we assessed the effects of aqueous 
artichoke leaf extracts on the T-47D and ZR-75-1 
human breast cancer cell lines the observed viability 
varied in function of concentration and time (see Table 
1). 
 Table 1.  
Concentration dependent variation of T47-D and ZR-75-1 cells’ viability.   
 
Aqueous artichoke 
treated cells 
2-day treatment 3-day treatment 
conc. range (%) viability conc. range (%) viability 
T-47D 10-0.63 4x↓ 10-0.63 5x↓ 
0.31 LD50 0.31 LD50 
0.08 1.2x↑ 0.08 1.2x↑ 
0.04 1.3x↑ 0.04 1.5x↑ 
ZR-75-1 10-0.63 6x↓ 10-0.63 8.5x↓ 
0.16 LD50 0.16 LD50 
0.04 1.2x↑ 0.04 1.2x↑ 
Note:↑indicates increased , while ↓ symbolizes decreased values. 
 
At higher artichoke leaf extract concentrations the 
breast cancer cell lines viability was reduced, while 
from the DL50 values on by further decreasing the 
extract concentration, the viability of cells started to 
increase and ultimately at the lowest concentration 
exceeded at about 1.2 times the viability of control 
cells. In other words, at higher concentrations, our 
aqueous artichoke leaf extract markedly reduced breast 
cancerous cell viability, while as the concentrations got 
lower, the inhibitory effect disappeared, and even an 
increased viability so a stimulatory effect could be 
observed.  
The overall shape the aqueous artichoke leaf extract 
induced concentration-dependent response is biphasic 
(see Fig. 1, 2, 5, 6). This kind of data are indicating a 
hormesis dose response that is characterized by a low 
concentration stimulation and a high concentration 
inhibition. Such a hormetic dose response was 
observed in case of chemicals and radiation, and it was 
suggested that biological stress responses should be 
integrated within a hormetic context (Mitchell, 2007; 
Calabrese and Baldwin, 2000; Calabrese, 1999; 
Calabrese and Baldwin, 1999). 
Hormesis implies different interpretations for the 
low and high dose responses. At high doses, within the 
toxicological concentration range, the measured values 
indicate cellular damage. The stimulation seen at low 
concentrations, more likely it represents the 
manifestation of an adaptive response that leads to 
modest increases related to some kind of biological 
performance.   
Our results put in the context of hormesis are 
suggesting that the elevated levels of toxicity seen in 
case of aqueous and alcoholic artichoke leaf extracts 
are presumably due to senescence and/or apoptosis, 
while the increased viability seen at low aqueous 
artichoke concentrations is probably related to some 
adaptive stress response that would facilitate the 
division of the examined cancerous cell lines. In this 
respect further studies are needed to establish what 
molecular and cellular mechanisms are contributing to 
this adaptive stress response, and it would be equally 
important to shed light on the mechanisms behind the 
high concentration toxicity of our artichoke leaf 
extracts.   
There are several considerations that we should 
take into account regarding future studies since the T-
47D and ZR-75-1 human breast cancer cell lines are 
extensively used in biomedical research, and are 
classified as estrogen receptor positive (Ford et al., 
2011). Estrogen receptor has been reported to play a 
critical role in promoting the growth of breast tumor 
cells. In the future, it would be of a great relevance to 
assess the estrogen receptor modulator effect of our 
extracts since for other plant extract (Huaier extract) 
significantly reduced the mRNA and protein levels of 
estrogen receptor α (ERα) in T-47D and ZR-75-1 ERα-
positive cell lines. The downregulation of ERα protein 
levels was correlated with activation of the 
proteasomes, and inhibition of the estrogen-stimulated 
proliferation and reversed the estrogen-induced 
activation of the nuclear factor κB (NFκB) pathway 
(Wang et al., 2013). Recently, it has been demonstrated 
that the malignant pleural mesothelioma cell lines were 
showing pronounced cytotoxicity when treated with 
artichoke leaf extract, and the identified misregulated 
pathways were related to cancer initiation and 
progression (Sharma et al., 2016).  Similarly we intend 
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to carry out the transcriptome analysis of the T-47D 
and ZR-75-1cells treated with our artichoke leaf  
extracts in order to assess the high concentration 
specific reduced viability, and low concentration 
induced increased viability as it would be very 
interesting to find out the artichoke induced gene 
expression associated with the hormetic response. 
Besides the applied extract concentrations we will have 
to pay attention to the duration of the treatments since 
it was demonstrated that at lower concentration 
exposure and longer incubation, the cancer cell growth 
had been inhibited via an apoptosis independent 
mechanism. Experimental data obtained on long term 
exposed MDA-MB231 human breast cancer cells to 
polyphenols extracted from the head of fresh artichoke 
did induce senescence driven growth arrest through 
epigenetic and ROS-mediated mechanisms (Mileo et 
al., 2015). 
All together our data are suggesting that the 
aqueous and alcoholic artichoke extracts might be 
applicable for the supplementations of certain anti-
tumor therapies. However, further studies are needed to 
carefully assess their potential effects before any step is 
taken regarding their use as complementary remedies. 
In this respect it would be important to take into 
account and assess the possible hepatoprotective effect 
of our artichoke extracts since we were able to identify 
several hepatoprotective bioactive compounds in them 
(Vígh et al., 2017, accepted for publication). It is 
known that the hepatotoxicity related to chemotherapy 
causes delays of treatment in cancer patients and often 
requires supplementation of anti-tumor therapy with 
hepatoprotective agents (Angelini et al., 2012). 
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